Cargando…

Sarcopenia in the Elderly

In the 21st century, life expectancy has increased and consequently so has the number of elderly people. Sarcopenia is an emerging area in geriatric medicine. The European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as a syndrome characterised by progressive and generalis...

Descripción completa

Detalles Bibliográficos
Autor principal: Dionyssiotis, Yannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Touch Medical Media 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587902/
https://www.ncbi.nlm.nih.gov/pubmed/31244904
http://dx.doi.org/10.17925/EE.2019.15.1.13
_version_ 1783429164132466688
author Dionyssiotis, Yannis
author_facet Dionyssiotis, Yannis
author_sort Dionyssiotis, Yannis
collection PubMed
description In the 21st century, life expectancy has increased and consequently so has the number of elderly people. Sarcopenia is an emerging area in geriatric medicine. The European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as a syndrome characterised by progressive and generalised loss of skeletal muscle mass and strength and/or physical performance, associated with a risk of adverse outcomes such as physical disability, poor quality of life, and death. Sarcopenia requires diagnostic and interventional methods in order to initiate timely and appropriate treatment. Diagnosing sarcopenia requires assessments of muscle mass, muscle strength and physical performance. Management of sarcopenia involves a variety of approaches. Nutritional and exercise interventions are strongly supported.
format Online
Article
Text
id pubmed-6587902
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Touch Medical Media
record_format MEDLINE/PubMed
spelling pubmed-65879022019-06-26 Sarcopenia in the Elderly Dionyssiotis, Yannis Eur Endocrinol Sarcopenia In the 21st century, life expectancy has increased and consequently so has the number of elderly people. Sarcopenia is an emerging area in geriatric medicine. The European Working Group on Sarcopenia in Older People (EWGSOP) defined sarcopenia as a syndrome characterised by progressive and generalised loss of skeletal muscle mass and strength and/or physical performance, associated with a risk of adverse outcomes such as physical disability, poor quality of life, and death. Sarcopenia requires diagnostic and interventional methods in order to initiate timely and appropriate treatment. Diagnosing sarcopenia requires assessments of muscle mass, muscle strength and physical performance. Management of sarcopenia involves a variety of approaches. Nutritional and exercise interventions are strongly supported. Touch Medical Media 2019-04 2019-04-12 /pmc/articles/PMC6587902/ /pubmed/31244904 http://dx.doi.org/10.17925/EE.2019.15.1.13 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/3.0/ Review Process: This article is a short opinion piece and has not been submitted to external peer reviewers, but has been accepted by our Editorial Board. Compliance With Ethics: This article is an opinion piece and does not report on new clinical data, or any studies with human or animal subjects performed by any of the authors. Authorship: The author meets the criteria of the International Committee of Medical Journal Editors for authorship for this manuscript, takes responsibility for the integrity of the work as a whole and has given final approval for the version to be published.
spellingShingle Sarcopenia
Dionyssiotis, Yannis
Sarcopenia in the Elderly
title Sarcopenia in the Elderly
title_full Sarcopenia in the Elderly
title_fullStr Sarcopenia in the Elderly
title_full_unstemmed Sarcopenia in the Elderly
title_short Sarcopenia in the Elderly
title_sort sarcopenia in the elderly
topic Sarcopenia
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587902/
https://www.ncbi.nlm.nih.gov/pubmed/31244904
http://dx.doi.org/10.17925/EE.2019.15.1.13
work_keys_str_mv AT dionyssiotisyannis sarcopeniaintheelderly